![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/alfasigmas-pbc-treatment-ocaliva-to-face-an-fda-adcomm-in-september/
https://www.fiercepharma.com/pharma/after-two-fda-rejections-and-restructuring-plan-intercept-agrees-alfasigma-buyout
https://www.biospace.com/article/releases/alfasigma-acquires-the-entire-share-capital-of-sofar-an-italian-pharmaceutical-company/?s=79
https://endpts.com/alfasigma-snares-eu-rights-to-blood-clotting-antibody-on-the-hunt-for-patients-taking-astrazenecas-brilinta/
https://www.prnewswire.com/news-releases/alfasigma-rachete-a-phasebio-sa-licence-europeenne-du-bentracimab-878674342.html
https://www.prnewswire.com/news-releases/alfasigma-adquiere-la-licencia-europea-para-bentracimab-de-phasebio-812580038.html
https://www.globenewswire.com/news-release/2020/07/23/2066677/0/en/Alfasigma-USA-Inc-Engages-Indegene-Inc-to-Expand-the-Promotion-of-ZELNORM-to-Healthcare-Professionals-in-the-United-States.html